DNAPrint Genomics, Inc.
DNAG · OTC
9/30/2007 | 6/30/2007 | 3/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.01 | -0.00 | 0.03 |
| FCF Yield | -36.05% | -26.12% | -27.39% | -12.40% |
| EV / EBITDA | -5.96 | -7.67 | -10.19 | -8.18 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | -2.90% | 17.97% | 26.58% | 34.42% |
| Cash Conversion Ratio | 0.72 | 0.71 | -0.43 | 0.08 |
| Growth | ||||
| Revenue 3-Year CAGR | 22.79% | 38.23% | 44.18% | 45.76% |
| Free Cash Flow Growth | -12.86% | 3.25% | -157.04% | 63.43% |
| Safety | ||||
| Net Debt / EBITDA | -3.45 | -4.05 | -5.70 | -5.16 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.81 | 1.92 | 3.97 | 3.57 |
| Cash Conversion Cycle | -343.35 | -116.92 | -478.42 | -747.95 |